Foto del docente

Caterina Giannini

Full Professor

Department of Biomedical and Neuromotor Sciences

Academic discipline: MED/08 Pathology

Publications

Paolini M.A.; Kipp B.R.; Sukov W.R.; Jenkins S.M.; Barr Fritcher E.G.; Aranda D.; SantaCruz K.S.; Al-Dandan S.; Fisher P.; McDonald W.C.; Bondurant C.P.; Van Dyke Darkow G.; Giannini C.; Parisi J.E.; Jentoft M.E.; Raghunathan A., Sellar region atypical teratoid/rhabdoid tumors in adults: Clinicopathological characterization of five cases and review of the literature, «JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY», 2018, 77, pp. 1115 - 1121 [Scientific article]

Palsgrove D.N.; Brosnan-Cashman J.A.; Giannini C.; Raghunathan A.; Jentoft M.; Bettegowda C.; Gokden M.; Lin D.; Yuan M.; Lin M.-T.; Heaphy C.M.; Rodriguez F.J., Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association, «MODERN PATHOLOGY», 2018, 31, pp. 1787 - 1800 [Scientific article]

Kiyofuji S.; Perry A.; Graffeo C.S.; Giannini C.; Link M.J., The dangers of the “Head Down” position in patients with untreated pituitary macroadenomas: case series and review of literature, «PITUITARY», 2018, 21, pp. 231 - 237 [Scientific article]

Sahm F.; Reuss D.E.; Giannini C., WHO 2016 classification: changes and advancements in the diagnosis of miscellaneous primary CNS tumours, «NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY», 2018, 44, pp. 163 - 171 [Scientific article]

Louis D.N.; Wesseling P.; Paulus W.; Giannini C.; Batchelor T.T.; Cairncross J.G.; Capper D.; Figarella-Branger D.; Lopes M.B.; Wick W.; van den Bent M., cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC), «ACTA NEUROPATHOLOGICA», 2018, 135, pp. 481 - 484 [Scientific article]

Louis D.N.; Giannini C.; Capper D.; Paulus W.; Figarella-Branger D.; Lopes M.B.; Batchelor T.T.; Cairncross J.G.; van den Bent M.; Wick W.; Wesseling P., cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant, «ACTA NEUROPATHOLOGICA», 2018, 135, pp. 639 - 642 [Scientific article]

Johnson D.R.; Guerin J.B.; Giannini C.; Morris J.M.; Eckel L.J.; Kaufmann T.J., 2016 updates to the WHO brain tumor classification system: What the radiologist needs to know, «RADIOGRAPHICS», 2017, 37, pp. 2164 - 2180 [Scientific article]

Pekmezci M.; Rice T.; Molinaro A.M.; Walsh K.M.; Decker P.A.; Hansen H.; Sicotte H.; Kollmeyer T.M.; McCoy L.S.; Sarkar G.; Perry A.; Giannini C.; Tihan T.; Berger M.S.; Wiemels J.L.; Bracci P.M.; Eckel-Passow J.E.; Lachance D.H.; Clarke J.; Taylor J.W.; Luks T.; Wiencke J.K.; Jenkins R.B.; Wrensch M.R., Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT, «ACTA NEUROPATHOLOGICA», 2017, 133, pp. 1001 - 1016 [Scientific article]

Prasad N.K.; Tubbs R.S.; Amrami K.K.; Dyck P.J.B.; Mauermann M.L.; Giannini C.; De Divitiis O.; Spinner R.J., Can intraneural perineuriomas occur intradurally? An anatomic perspective, «NEUROSURGERY», 2017, 80, pp. 226 - 234 [Scientific article]

Korfel A.; Schlegel U.; Johnson D.R.; Kaufmann T.J.; Giannini C.; Hirose T., Case-based review: Primary central nervous system lymphoma, «NEURO ONCOLOGY PRACTICE», 2017, 4, pp. 46 - 59 [Scientific article]

Johnson D.R.; Diehn F.E.; Giannini C.; Jenkins R.B.; Jenkins S.M.; Parney I.F.; Kaufmann T.J., Genetically defined oligodendroglioma is characterized by indistinct tumor borders at MRI, «AJNR, AMERICAN JOURNAL OF NEURORADIOLOGY», 2017, 38, pp. 678 - 684 [Scientific article]

Shankar G.M.; Abedalthagafi M.; Vaubel R.A.; Merrill P.H.; Nayyar N.; Gill C.M.; Brewster R.; Bi W.L.; Agarwalla P.K.; Thorner A.R.; Reardon D.A.; Al-Mefty O.; Wen P.Y.; Alexander B.M.; Van Hummelen P.; Batchelor T.T.; Ligon K.L.; Ligon A.H.; Meyerson M.; Dunn I.F.; Beroukhim R.; Louis D.N.; Perry A.; Carter S.L.; Giannini C.; Curry W.T.; Cahill D.P.; Barker F.G.; Brastianos P.K.; Santagata S., Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas, «NEURO-ONCOLOGY», 2017, 19, pp. 535 - 545 [Scientific article]

Cavalli F.M.G.; Remke M.; Rampasek L.; Peacock J.; Shih D.J.H.; Luu B.; Garzia L.; Torchia J.; Nor C.; Morrissy A.S.; Agnihotri S.; Thompson Y.Y.; Kuzan-Fischer C.M.; Farooq H.; Isaev K.; Daniels C.; Cho B.-K.; Kim S.-K.; Wang K.-C.; Lee J.Y.; Grajkowska W.A.; Perek-Polnik M.; Vasiljevic A.; Faure-Conter C.; Jouvet A.; Giannini C.; Nageswara Rao A.A.; Li K.K.W.; Ng H.-K.; Eberhart C.G.; Pollack I.F.; Hamilton R.L.; Gillespie G.Y.; Olson J.M.; Leary S.; Weiss W.A.; Lach B.; Chambless L.B.; Thompson R.C.; Cooper M.K.; Vibhakar R.; Hauser P.; van Veelen M.-L.C.; Kros J.M.; French P.J.; Ra Y.S.; Kumabe T.; Lopez-Aguilar E.; Zitterbart K.; Sterba J.; Finocchiaro G.; Massimino M.; Van Meir E.G.; Osuka S.; Shofuda T.; Klekner A.; Zollo M.; Leonard J.R.; Rubin J.B.; Jabado N.; Albrecht S.; Mora J.; Van Meter T.E.; Jung S.; Moore A.S.; Hallahan A.R.; Chan J.A.; Tirapelli D.P.C.; Carlotti C.G.; Fouladi M.; Pimentel J.; Faria C.C.; Saad A.G.; Massimi L.; Liau L.M.; Wheeler H.; Nakamura H.; Elbabaa S.K.; Perezpena-Diazconti M.; Chico Ponce de Leon F.; Robinson S.; Zapotocky M.; Lassaletta A.; Huang A.; Hawkins C.E.; Tabori U.; Bouffet E.; Bartels U.; Dirks P.B.; Rutka J.T.; Bader G.D.; Reimand J.; Goldenberg A.; Ramaswamy V.; Taylor M.D., Intertumoral Heterogeneity within Medulloblastoma Subgroups, «CANCER CELL», 2017, 31, pp. 737 - 754.e6 [Scientific article]

Buckner J.; Giannini C.; Eckel-Passow J.; Lachance D.; Parney I.; Laack N.; Jenkins R., Management of diffuse low-grade gliomas in adults - Use of molecular diagnostics, «NATURE REVIEWS. NEUROLOGY», 2017, 13, pp. 340 - 351 [Scientific article]

Brown P.D.; Ballman K.V.; Cerhan J.H.; Anderson S.K.; Carrero X.W.; Whitton A.C.; Greenspoon J.; Parney I.F.; Laack N.N.I.; Ashman J.B.; Bahary J.-P.; Hadjipanayis C.G.; Urbanic J.J.; Barker F.G.; Farace E.; Khuntia D.; Giannini C.; Buckner J.C.; Galanis E.; Roberge D., Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial, «THE LANCET ONCOLOGY», 2017, 18, pp. 1049 - 1060 [Scientific article]

Latest news

At the moment no news are available.